Sheaff Brock Investment Advisors, LLC Collegium Pharmaceutical, Inc Transaction History

Sheaff Brock Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$31.23 - $40.91 $163,957 - $214,777	5,250 New	5,250 $203,000
Q3 2019 Oct 28, 2019	SELL	$10.16 - $13.28 $179,324 - $234,392	-17,650 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$10.62 - $16.59 $31,859 - $49,770	-3,000 Reduced 14.53%	17,650 $232,000
Q1 2019 Apr 29, 2019	BUY	$13.58 - $18.72 $36,326 - $50,076	2,675 Added 14.88%	20,650 $313,000
Q4 2018 Jan 28, 2019	SELL	$14.78 - $19.68 $121,935 - $162,360	-8,250 Reduced 31.46%	17,975 $309,000
Q3 2018 Nov 09, 2018	SELL	$14.16 - $24.3 $10,974 - $18,832	-775 Reduced 2.87%	26,225 $387,000
Q2 2018 Jul 31, 2018	BUY	$21.79 - $28.29 $336,655 - $437,080	15,450 Added 133.77%	27,000 $644,000
Q1 2018 May 03, 2018	BUY	$18.15 - $29.21 $209,632 - $337,375	11,550 New	11,550 $295,000

236

39.4M

84.2K

18.6K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.32B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.